Delivery Order SPE2DR25D1106-SPE2DR26FJB8E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...
- The Defense Logistics Agency awarded a delivery order valued at $8,717.35 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, a pharmaceutical product used primarily for immunosuppression in transplant patients and certain autoimmune conditions. This competitively awarded, non-set-aside contract has a ceiling value of $9,624.81 with a firm fixed price structure and an ultimate completion date of October 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $7,015.33. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,236.08 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) with a firm fixed price contract type. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, and the product will be performed from the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) with a ceiling value of $17,869.02 under a firm fixed-price contract type. The award was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and utilized no set-aside designation, indicating the award was competitively procured. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the specified place of performance—is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $2,407.68. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 29, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $19,770.34. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $5,074.60. This is a firm fixed-price delivery order under an indefinite delivery contract vehicle, with an ultimate completion date of November 10, 2025. The contract was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB8EDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $34,182.88 for 100-count bottles of CellCept 500 mg tablets, with a completion date of December 3, 2025. This non-competitive delivery order was issued without a set-aside designation and represents a standard pharmaceutical procurement supporting military healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and healthcare commodities to support military and veteran healthcare systems globally. CellCept, an immunosuppressant medication, represents the type of specialized pharmaceutical product available through this vehicle, which serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor with established federal procurement capabilities, AmerisourceBergen continues to fulfill critical medical supply needs through competitively awarded contracts and designated prime vendor agreements across the defense logistics network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 12/1/25 |